Kelowna, British Columbia / TheNewswire / September 7, 2018 - Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces strategic additions to its patent portfolio.
Read more
Lexaria Receives Three Patent Grants and Two Notices of Allowance; Provides Patent Portfolio Guidance
